TECNALIA is leading the development of a groundbreaking prototype for non-invasive neuromodulation for diseases such as stroke and Parkinson

The center for applied research and technological development has led the development of a system that guides and transports nanoparticles across the blood-brain barrier and uses them to modulate the activity of target neurons with pinpoint precision. This groundbreaking development was made possible through a collaboration with Achucarro, DIPC, CFM, FBB, CUN, Bitbrain, and the University of the Basque Country

Go to Source